Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) has recently seen a 25% increase in its shares. However, the company is still facing challenges due to insufficient growth. Despite the rise in stock value, Aurinia Pharmaceuticals Inc. is struggling to show significant growth. Investors are cautious as the company continues to face obstacles in expanding its business. It remains to be seen if Aurinia Pharmaceuticals Inc. can overcome these challenges and achieve sustainable growth in the future.
Subscribe
Login
0 Comments